You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for New Drug Application (NDA): 022388


✉ Email this page to a colleague

« Back to Dashboard


NDA 022388 describes ACUVUE THERAVISION WITH KETOTIFEN, which is a drug marketed by Johnson Johnson Visn and is included in one NDA. There are two patents protecting this drug. Additional details are available on the ACUVUE THERAVISION WITH KETOTIFEN profile page.

The generic ingredient in ACUVUE THERAVISION WITH KETOTIFEN is ketotifen fumarate. There are five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ketotifen fumarate profile page.
Summary for 022388
Medical Subject Heading (MeSH) Categories for 022388

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:DRUG-ELUTING CONTACT LENS;OPHTHALMICStrengthEQ 19MCG BASE
Approval Date:Feb 25, 2022TE:RLD:Yes
Regulatory Exclusivity Expiration:Feb 25, 2025
Regulatory Exclusivity Use:NEW PRODUCT
Patent:⤷  Sign UpPatent Expiration:Mar 27, 2028Product Flag?YSubstance Flag?Delist Request?
Patent:⤷  Sign UpPatent Expiration:Jun 27, 2030Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.